Want to see SABS full AI Analyst Report?
SAB Biotherapeutics (SABS) Ownership Overview
14.61% Insiders
2.86% Mutual Funds
51.79% Other Institutional Investors
5.69% ETFs
25.04% Public Companies and
Individual Investors
The ownership structure of SAB Biotherapeutics (SABS) stock is a mix of institutional, retail, and individual investors. Approximately 60.35% of the company’s stock is owned by Institutional Investors, 14.61% is owned by Insiders, and 25.04% is owned by Public Companies and Individual Investors.
Recent Hedge Fund Trading Activity
Date | Firm | Activity | Value |
|---|---|---|---|
Mar 31, 2026 | xxxxxxxxxxxxx | $10922360 | |
Mar 31, 2026 | xxxxxxxxxxxxx | $24633576 | |
Mar 31, 2026 | xxxxxxxxxxxxx | $3294451 |
Top Shareholders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 6,627,501 | Institution | 7.28% | 25,051,954 | |
| 5,232,304 | Insider | 5.75% | 19,778,109 | |
| 4,401,500 | Institution | 4.84% | 16,637,670 | |
| 3,195,208 | Institution | 3.51% | 12,077,886 | |
| 2,857,142 | Insider | 3.14% | 10,799,997 | |
| 2,428,287 | Institution | 2.67% | 9,178,925 | |
| 2,198,457 | Insider | 2.42% | 8,310,167 | |
| 2,198,457 | Insider | 2.42% | 8,310,167 | |
| 1,574,960 | Institution | 1.73% | 5,953,349 | |
| 1,180,355 | Institution | 1.30% | 4,461,742 |
Top Mutual Fund Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 2,428,287 | Institution | 2.67% | 9,178,925 | |
| 102,912 | Institution | 0.11% | 389,007 | |
| 37,595 | Institution | 0.04% | 142,109 | |
| 27,855 | Institution | 0.03% | 105,292 | |
| 7,880 | Institution | <0.01% | 29,786 |
Top ETF Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 2,259,593 | Institution | 2.48% | 8,066,747 | |
| 1,041,090 | Institution | 1.14% | 3,935,320 | |
| 647,886 | Institution | 0.71% | 2,312,953 | |
| 382,211 | Institution | 0.42% | 1,444,758 | |
| 244,596 | Institution | 0.27% | 873,208 | |
| 151,468 | Institution | 0.17% | 572,549 | |
| 104,849 | Institution | 0.12% | 396,329 | |
| 91,497 | Institution | 0.10% | 346,774 | |
| 88,735 | Institution | 0.10% | 335,418 | |
| 53,744 | Institution | 0.06% | 203,152 |
FAQ
Who Owns SAB Biotherapeutics (SABS)?
According to the latest TipRanks data, approximately 51.79% of the company's stock is held by institutional investors, 14.61% is held by insiders, and 25.04% is held by retail investors.
What percentage of SAB Biotherapeutics (SABS) stock is held by institutional investors?
According to the latest TipRanks data, approximately 51.79% of SAB Biotherapeutics (SABS) stock is held by institutional investors.
What percentage of SAB Biotherapeutics (SABS) stock is held by retail investors?
According to the latest TipRanks data, approximately 25.04% of SAB Biotherapeutics (SABS) stock is held by retail investors.
Who owns the most shares of SAB Biotherapeutics (SABS)?
Joseph Edelman owns the most shares of SAB Biotherapeutics (SABS).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.